Compounds made from Adamantilidida derivatives and receptor 5 glutamate metabolite (MGLUR5) of Western Sahara modulator； pharmacological synthesis containing these substances； and used in the treatment of SNC diseases or disorders, such as depression, anxiety disorders, schizophrenia and Parkinson's disease.
<；p>； Adamantildiamide-derived compounds, allosteamic modulators of the metabotropic glutamate 5 receptor； pharmaceutical composition that includes them； and use to treat a CNS disease or disorder such as depression, anxiety, schizophrenia, and Parkinson's disease. <；/p>；<；p>；Compuestos derivados de adamantildiamida, moduladores alosté；ricos del receptor 5 glutamato metabotró；pico； composició；n farmacé；utica que los comprende； y uso para tratar una enfermedad o trastorno del snc tal como depresió；n, ansiedad, esquizofrenia y enfermedad de Parkinson.<；/p>；
